Sort
35,931 grants matching “parkinsons”
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$357,549Mark M Davis · Stanford University · P01 · FY2025 · AI
Phosphine-Catalyzed Annulations and their Applications
$357,525Ohyun Kwon · University Of California Los Angeles · R01 · FY2025 · GM
Phosphine-Catalyzed Annulations and their Applications
$357,525Ohyun Kwon · University Of California Los Angeles · R01 · FY2024 · GM
Core C: Analytical Core
$357,524Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2020 · AG
Core C: Analytical Core
$357,524Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2021 · AG
Core C: Analytical Core
$357,524Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2019 · AG
Core C: Analytical Core
$357,522Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2017 · AG
Parkinson's Disease Clinical Trial: Statistical Center
$357,500Medical University Of South Carolina · U01 · FY2001 · NS
LENTIVIRAL DELIVERY OF GDNF AND BCL-2 IN PD MODEL
$357,500Rush University Medical Center · R01 · FY2000 · NS
Impact of Endogenous DOPA Signaling on Melanocyte Homeostasis and Melanoma Susceptibility
$357,500Todd W Ridky · University Of Pennsylvania · R56 · FY2021 · AR
Molecular Mechanisms of Neuronal Differentiation
$357,438State University New York Stony Brook · R01 · FY2004 · NS
Molecular Mechanisms of Neuronal Differentiation
$357,438State University New York Stony Brook · R01 · FY2002 · NS
Molecular Mechanisms of Neuronal Differentiation
$357,438State University New York Stony Brook · R01 · FY2005 · NS
Molecular Mechanisms of Neuronal Differentiation
$357,438State University New York Stony Brook · R01 · FY2003 · NS
Repositioning Gliptins for Parkinson's Disease Treatment
$357,406Barry J Hoffer · Case Western Reserve University · R01 · FY2015 · NS
SUPPORT OF YERKES NATIONAL PRIMATE RESEARCH CENTER
$357,359Michael M Johns · Emory University · P51 · FY2008 · RR
Role of the Male-Specific Factor Sry in Brain Function
$357,326Eric J Vilain · University Of California Los Angeles · R01 · FY2011 · MH
The neural bases of placebo effects and their relation to regulatory processes
$357,311Tor Dessart Wager · Columbia Univ New York Morningside · R01 · FY2007 · MH
Function of hematopoietically-derived myeloid precursors to the central nervous s
$357,300Josef Kurtz · Emmanuel College · R15 · FY2014 · NS
LRRK2 in Parkinson's Disease Neurodegeneration
$357,294Ian Martin · Oregon Health & Science University · R01 · FY2022 · NS
Molecular Chaperones in Lewy Body Diseases
$357,237Bradley T Hyman · Massachusetts General Hospital · P50 · FY2008 · NS
Consequences of Synucleinopathy and Dopamine Depletion
$357,234Ann M Graybiel · Massachusetts General Hospital · P50 · FY2008 · NS
Neuronal Cell Cycle and Survival
$357,234Nicholas E Baker · Albert Einstein College Of Medicine · R01 · FY2015 · EY
Novel Neuroprotective Treatment for Parkinson's Disease
$357,215Aloke K Dutta · Wayne State University · R01 · FY2008 · NS
Genetic Analysis of Onset Age of Parkinson's Disease
$357,212Wadsworth Center · R01 · FY2002 · NS